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ABSTRACT 
Genome editing has created a new continuum between what might occur in nature and 
what can only occur in the laboratory. Remarkable though it is that we have developed the 
capacity to predictably and finely alter genetic codes it is perhaps as remarkable that a new 
technology enabling this has appeared, spread widely and become easily affordable and 
accessible within such a short timescale. The speed at which the CRISPR/Cas9 technology 
use has grown almost defies comparison. A factor contributing to this, and also to the 
complexity of the surrounding debates, is the sheer breadth of possible applications of the 
technology, in terms of target organisms and genetic constructs, and in terms of the 
processes it could be used to influence. These combined characteristics, while opening a 
world of possibilities for science and society, also present a pressing and complex set of 
questions about governance and regulation; it is difficult to have appropriately informed 
discussion let alone for regulation to keep pace.  
There is good reason to anticipate that genome editing will continue to progress rapidly and 
to evolve more refined, and perhaps even more accessible, characteristics and capacities. 
Decisions about where and whether to apply the technology in controversial settings are 
already arising, and will continue to do so – the full range of contexts is difficult to 
anticipate. It is certainly the case that the pull on science and its applications from current 
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big challenges in food security and sustainability; the interaction of nutrition and health; the 
regulatory environment and its adaptation; societal perception of genetic engineering and 
its drivers; will soon combine to create the context in which the application of genome 
editing to agriculture will play out. It is vital that scientists play an active, engaged and highly 
reflective role in this, both in technical communication with the sector and non-technical 
communication with public, business and policymakers. 
Governments and business are wrestling with big challenges in food and nutritional security 
-  predominantly the need to improve the available supply of nutritious food to expanding 
populations without increasing resource use in terms of land, water, energy, the application 
of chemicals (biocides and fertilisers), or contributing to greenhouse gas (GHG) emissions 
driving climate change. The search for knowledge of gene function to identify solutions to 
these challenges is generally encouraged at the research stage but often controversial in 
public and at the stage of application. Publicly and privately funded research has a role to 
play and therefore all scientist communities must be involved in responsible research and 
innovation as well as dialogue with stakeholder communities.   
Existing legal and regulatory frameworks do not necessarily cover the possibilities emerging 
from genome editing, and new regulations will be needed in many jurisdictions. The very 
basic question of whether genome editing will, or will not, be regarded by regulators as 
genetic modification (GM) remains unresolved at the EU level, although some recent 
decisions in the USA have provided judgement on individual altered organisms.5 The 
technical detail of whether a point substitution or deletion is involved, as opposed to 
CRISPR-mediated insertion of sizable sections of DNA, is often seen as a determining factor 
within the science community, but may not be so in the regulatory community, or in public.6 
Equally whether the absence of trans-genes exempts a modified organism from GMO status 
is also debated. However, continued delay and uncertainty in the EU, and elsewhere, will 
                                                          
5 Anti-browning trait white button mushroom: 
https://www.aphis.usda.gov/biotechnology/downloads/reg_loi/15-321-01_air_response_signed.pdf; 
Waxy corn hybrid: https://www.aphis.usda.gov/biotechnology/downloads/reg_loi/15-352-
01_air_response_signed.pdf  
6 VBIO (2016) Genome Editing bei Pflanzen: Biologenverband für pragmatischen Umgang im geltenden 
Rechtsrahmen  
http://www.vbio.de/vbio/content/e25/e15139/e15146/e36447/filetitle/160914_PM_Impuls_Genome_Editing
_ger.pdf  
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deter some innovation, while the creation of certainty around a legal environment would 
facilitate planning and development.  
It is a genuinely challenging task to create a regulatory environment and mechanisms that 
recognise what should be permitted without closing off innovation or dissuading further 
development. However, this is essential in order to strike the right balance between having 
sufficient rigour to benefit the public, and introducing a hurdle (or series) that stifles 
innovation.  
This challenge will require important decision-making among biologists, social scientists, the 
legal profession, ethicists, policy-makers and, importantly, the general public, to reach the 
best starting point for any regulatory framework. Ideally, this will enable continued 
exploration and innovation. Design of appropriate regulation must also build in capacity to 
adapt the mechanism and its framing based on the experience accumulated and the new 
questions that emerge. Early consideration of public and stakeholder issues is required to 
provide the strong foundation on which a regulatory framework can rest. Past experience in 
GMO debates and elsewhere indicates that mistrust can be difficult to address once it has 
emerged. Equally, it can be difficult to anticipate where the most obvious benefits of a new 
technology will accrue first. Early applications of new technologies often come to define the 
popular public view of a technology and can have undue influence on attitudes to 
subsequent applications regardless of any difference in character. In this context, regulation 
of genome editing must be tailored and adaptable as our understanding of the operation, 
potential and implications of these techniques improves.  
 
As the possibility of release or use of genome edited organisms approaches, the 
characteristics and requirements of the regulatory system must be considered. The products 
of safe research, if recognised by the informed public as acceptable and sustainable, should 
not face a regulatory block. Any regulation must address a number of issues, only some of 
which can ever be answered by science. Technical and safety concerns are amongst those 
that can be approached objectively and potentially can be resolved, predominantly by 
science. 
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Nevertheless, regulation of genome edited organisms is complicated by the fact that certain 
applications, which do not introduce transgenes, may be effectively indistinguishable (in 
terms of sequencing) from those generated by traditional breeding techniques. Deletions, 
substitutions or small-scale insertions of genetic sequences can be introduced by either 
conventional breeding techniques or, more rapidly, using genome editing. It may be 
impossible to discern by sequence analysis which process produced the new organism, and 
yet the timelines for generating these products are likely to be dramatically different. 
Transparency and trustworthiness on the part of product developers is essential here, as in 
other areas of science. Ensuring that there are no perverse incentives in the regulatory 
system will be important in supporting this. Estimates vary, but it is not unreasonable to 
predict that editing techniques could more than halve the time required to develop crops 
carrying a novel trait. The clear advantage afforded by this speed is a more rapid route to 
addressing any urgent challenge from disease, or to get a product to market to meet a need. 
However, it is not inconceivable that a slow and cumbersome regulatory system could erode 
the time advantage in development.  It is increasingly likely that combinations of 
technologies will be used to generate novel varieties – a capacity to assess and 
accommodate the combination of a range of technologies is therefore desirable but not 
straightforward.  
Moral and ethical considerations must be addressed by society, and for each society this will 
be informed by inherent moral frameworks in operation. Increasingly, fairness and equity in 
the beneficial outcomes of research and innovation are key concerns for citizens assessing 
the acceptability of applied science.   
Agriculture and food production carry particular cultural and ethical contexts as well as the 
very essential function of nutrition and provision of sustenance. Genome editing, as with 
other technological developments, has the capacity to alter the socioeconomic structures 
affecting farmers and food producers, life-course and welfare of farm animals, and the 
impact of farm animals and crops on surrounding biodiversity. The speed of progress and 
breadth of application alone are reasons for special attention. Scientists involved in 
development programmes have a role to explain their motivation and aspiration on 
generating new products and how these can address existing challenges.   
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Previous technological developments have become intimately bound to a range of issues 
unrelated to the science behind their development. To many, GMOs are intrinsically linked 
with the operation of large corporations, an issue compounded by the fact that few, other 
than those large corporations, can afford to take new products through the regulatory 
approval system. In particular, concerns surrounding GM crops focus on the progressive 
concentration of land and resources in the hands of a few (and to the detriment of local 
small-holders and small-scale farmers) and a potential burden of litigation on farmers 
planting GM crops if neighbouring crops are shown to have acquired GM material.7,8  
Animal welfare implications of genome editing are complex. On the one hand the 
technology has already been shown to have particular promise in disease resistance 
breeding, potentially removing a significant burden of illness and early death,9 or removing 
characteristics unsuited to a farm setting (e.g. hornless cattle). There are some objectors to 
livestock farming in principle who cannot be convinced of the merits of genome editing, but 
there is clear scope for engagement with others on a case-by-case basis. Agricultural impact 
on the environment and biodiversity is particularly relevant in relation to disease control 
and is likely to be complex, with the need to carefully assess all potential risks before 
proceeding. Genome editing of insect disease vectors for example, involving release (and 
potentially incorporation of gene drive features, see below) requires careful analysis in 
relation to ecosystem function.  
Alongside the possibilities afforded by utilising genome editing techniques on domesticated 
species of crop or livestock, it is possible that CRISPR/Cas9 could be used to design gene 
drives designed to spread in wild populations. A gene drive is a genetically determined 
characteristic that can spread through a population, over multiple generations, at a rate 
faster than would be possible through Mendelian inheritance. In theory, gene drives could 
be used to spread a desired characteristic through an entire wild species. The potential 
applications for such a technology are evident, from reducing the ability of disease vectors 
                                                          
7 IAASTD (2009) Agriculture at a Crossroads 
http://www.unep.org/dewa/agassessment/reports/IAASTD/EN/Agriculture%20at%20a%20Crossroads_Synthe
sis%20Report%20%28English%29.pdf;  
8 Encyclical Letter Laudato Si (2015) http://w2.vatican.va/content/francesco/en/encyclicals/documents/papa-
francesco_20150524_enciclica-laudato-si.html#_ftnref113.  
9Lillico, S.G., et al. (2013) Live pigs produced from genome edited zygotes. Scientific Reports 3: 2847 
http://www.nature.com/articles/srep02847  
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to carry a pathogen, to supressing the population of a given species by disrupting their 
reproductive efficiency. Whilst targeting vectors of human disease in this manner has 
received most attention, it is technically feasible to apply gene drive technologies in other 
settings, including the introduction of chosen traits to agriculturally important insect pests 
or other wild species. 
No gene drive organisms have been released to date and gene drives targeting agricultural 
pests remain theoretical. Nevertheless research into gene drives requires particular 
consideration and early engagement with stakeholders, because in theory at any rate, a 
single gene drive organism released into the wild could pass on its engineered trait to 
(eventually, for example in the absence of negative natural selection pressure) all progeny 
of  the species. That means that a decision to release gene drive organisms in one 
jurisdiction, under the local regulations, should take into account all other habitats of the 
species; ie the release of a gene drive should be considered globally. In all probability the 
number of species for which this approach might be appropriate is very low. 
A proposed nuance arises through so-called “daisy-chain” gene drives10, which are designed 
to persist for only a defined number of generations before disappearing again. Daisy-chain 
drives could be used to target invasive species only in their non-native range therefore, or 
suppress pest populations in a local area; this might offer a more applicable and perhaps 
more widely acceptable technology. However, careful, gradual and monitored moves 
towards testing are essential. 
The checks and controls required to police this kind of research are varied and should 
include molecular containment (separating drive elements) physical containment (the 
laboratory containment) and ecological (eco-system containment, whereby research on a 
particular species should not occur in areas where wild individuals of that species are 
present)11. Alongside this and of absolute necessity will be the training in practice and 
communication of responsible research at all levels of involvement12.  
                                                          
10 Noble et al., (2016) Daisy-chain gene drives for the alteration of local populations, bioRXiv, posted 2016 
11 Oye et al., (2014) Regulating gene drives. Science 345: 626-628 
12 Akbari et al., (2015) Safeguarding gene drive experiments in the laboratory. Science, 349: 927-929 
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The targeting of pest species or vectors of animal disease may offer realistic alternatives 
solutions to problems currently addressed by the use of pesticides - leading some to label 
them as “sustainable” agriculture options.13 Care should be taken when using terms such as 
this, given the complexity of the issues involved, and absolute transparency around any 
application of the technology and how this achieves its aims is essential, including 
justification of how this might achieve well-understood objectives of sustainability. 
Nevertheless, new technologies offer alternatives to current practice and should receive 
open analysis of benefit. Criticism of the current regulation of GM technologies in Europe 
often focuses on their failure to take into account risks associated with existing, non-GM 
solutions14.  
The potential for deliberate misuse of genome editing technologies to inflict damage on 
agricultural systems, and thereby on businesses, populations or nations, cannot be ignored. 
In this context the recent report of the Nuffield Council for Bioethics noted that “New  
possibilities  raised  by  convergence  of  genome  editing  and  gene  drive technologies may 
become a matter of increasing concern as the technologies develop.” Robust detection and 
counter-measures as well as strong normative values within the science community will be 
important15.  
 
Despite the novelty of genome editing, the bedrock issues that will be pivotal are familiar – 
being trustworthy and listening communicators will be vital for scientists if they want to be 
supported to continue good work in this area. The life sciences community has not just a 
role but a duty to raise awareness. Having governance capacity to truly minimise risks would 
bring real benefits. Active dialogue between researchers, research leaders, funders, 
authorities and civil society should underpin this. The UK is a good environment in which to 
                                                          
13 Montenegro, M. (2016) CRISPR is coming to agriculture — with big implications for food, farmers, consumers 
and nature.   
http://ensia.com/voices/crispr-is-coming-to-agriculture-with-big-implications-for-food-farmers-consumers-
and-nature/  
14 House of Lords Science and Technology Select Committee (2015) Genetically Modified Insects. 1st Report of 
Session 2015–16.  
15 RSB statement on responsible research and dual use research of concern 
https://www.rsb.org.uk/policy/policy-issues/dual-use-of-research  
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approach this. We need to be very aware of public preferences and priority topics because 
all forms of public support will be needed – funding, regulatory and popular.   
 
Openness and transparency can be effective in winning support. But scientists must show 
themselves to be independent and trustworthy – with the highest standards of reporting 
and self-criticism.  Science must be absolutely honest in the presentation of facts and 
assessment of risks and benefits. The temptation to over-simplify the pros and cons has real 
risk if it over-sells the specificity for techniques for example; CRISPR/Cas9 was presented as 
exquisitely precise in early discussion so when reports of improved techniques with higher 
efficiency and fewer off-target effects appear the implication is not lost on the listening 
public.  Additionally, clear communication that genetic assessment of edited organisms 
must be accompanied by phenotypic assessment should be stressed  
Genuine public engagement that can inform policy development is not easy to achieve. 
Encouraging and empowering life scientists to join in development and delivery of any 
engagement is crucial. And again this is not easy. It is essential that all scientists utilising 
gene editing techniques consider and try to fully understand the ethical and societal 
implications of their work, as well as the legal ones. Scientists are not necessarily trained, or 
experienced in communicating in these areas however. A greater attention to this challenge 
would benefit the profession overall, as well as future applications of genome editing. 
Provision of skills and training to engage with these issues will be essential to creating an 
informed scientific workforce. There are distinct training needs in relation to each aspect of 
this. Recognition is needed that while not everyone has the capacity or resource to engage 
publicly, all should understand the context and issues. 
 
Presentations at Genome Editing and the Future of Farming16 amply demonstrated 
awareness and thoughtfulness in the science community in the motivation and means 
employed in using genome editing to address challenges in agriculture. We need more and 
wider discussion of the issues and possibilities of genome editing to truly advance practice 
and its beneficial applications.  We must not wait for a public controversy or crisis before 
                                                          
16 Genome Editing and the Future of Farming (2016) http://www.nib.ac.uk/event/genome-editing-and-the-
future-of-farming/  
10 
 
National Institutes of Bioscience Journal 2016, Vol. 1    
http://www.nibjournal.ed.ac.uk/   http://dx.doi.org/10.2218/natlinstbiosci.1.2016.1748 
beginning to engage and communicate. We need to think and talk about the combined 
possibilities from genome editing, gene drive, current GM, marker assisted and conventional 
breeding technologies. Overall we must be ready to disaggregate the issues as much as 
possible and communicate about products and purpose, risks and benefits, as well as 
processes.  
 
 
 
 
 
 
